FDA cites higher death risk in Sanofi drug study - BusinessWeek

[INCIID News Feed]

KSDK
<img alt="" height="1" width="1" />
FDA cites higher death risk in Sanofi drug study
BusinessWeek
Federal health regulators are warning doctors that a heart drug from Sanofi was associated with fatal heart problems in a recently halted company study. The Food and Drug Administration reported Thursday that Sanofi halted a trial of its drug Multaq ...
FDA Warning on Atrial Fibrillation Drug MultaqWebMD
FDA Issues Alerts on the Heart Drug MultaqNew York Times
FDA joins Multaq review, reveals prelim study dataFiercePharma
Reuters -Wall Street Journal
all 207 news articles &raquo;


More...